Pharmaceutical company perspectives on current safety risk communications in Japan
نویسندگان
چکیده
In 1987, a group infection of hepatitis in patients receiving a contaminated fibrinogen product was first reported to the Japanese regulatory agency. Eventually, this serious drug incident involved more than 10,000 cases of infection. In response, the Government of Japan established a responding inspection committee in 2008 to make recommendations for the restructuring of drug regulatory administration. The final report was issued in 2010. One agenda item of this restructuring was the improvement of drug-related safety risk communications. Our research group on drug safety risk communications, which is funded by the Government of Japan, surveyed pharmaceutical companies regarding their perspective on current risk communications. The survey was conducted using an anonymous questionnaire developed for this study which included the three operational domains of targets, contents, and measures of drug risk communication. Fifty-two of the 74 member companies of the Post-marketing Surveillance Subcommittee of the Japan Pharmaceutical Manufacturer's Association participated, and this response rate of more than 70% was considered sufficient to ensure the external validity of the survey results. Results showed that the most highly prioritized aspect of risk messaging was the strength of evidence, and that outcome evaluation of risk communication gained recognition. Further, while physicians and pharmacists were the most prioritized communication targets, pharmacovigilance departments devoted the most resources to regulators, at more than 30%. The Internet was recognized as a useful public source of risk information, whereas Drug Guides for Patients delivered on the web were considered under-recognized. Further discussion of these results with the aim of enhancing the restructuring of the Japanese drug regulatory administration system are warranted.
منابع مشابه
Feasibility of high-dose iodine-131-metaiodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and hematopoietic stem cell transplantation: a study protocol
Objective(s): High-risk neuroblastoma is a childhood cancer with poorprognosis despite modern multimodality therapy. Internal radiotherapy using131I-metaiodobenzylguanidine (MIBG) is effective for treating the disease even if it isresistant to chemotherapy. The aim of this study is to evaluate the safety and efficacyof 131I-MIBG radiotherapy combined with myeloablative high-dose chemotherapyand...
متن کاملRisk assessment with intervention of gas pipelines repair using FMEA method and determination of safety performance monitoring: a case for a gas and oil operating company in 2012-13
Introduction: work-related accidents impose irreparable hurt on the national capital. It is necessary to take a series of preventive measures before the occurrence to preserve and protect the human force and reduce accidents. The current study aimed to check safety contradiction using the FMEA method and determine protection indicators of safety performance in the overhaul project. Materials ...
متن کاملA Safe and Sustainable Development in a Hygiene and Healthy Company Using Decision Matrix Risk Assessment Technique: a case study
This article describes the process of improving risk management practices in a foundry of the ALFET Company (Algeria). The proposed methodology is based on the decision matrix risk assessment technique. This technique allows making a risk assessment for each source of risk (machine, man, environment, and management), which leads to the determination of the overall risk rate during the activity ...
متن کاملThe Determinants of Research and Development Investment in the Pharmaceutical Industry: Focus on Financial Structures.
OBJECTIVES This study analyzes the influence of the financial structure of pharmaceutical companies on R&D investment to create a next-generation profit source or develop relatively cost-effective drugs to maximize enterprise value. METHODS The period of the empirical analysis is from 2000 to 2012. Financial statements and comments in general and internal transactions were extracted from TS-2...
متن کامل